Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Statins combined with exercise are associated with the increased renal function mediated by high-molecular-weight adiponectin in coronary artery disease patients.

Toyama K, Sugiyama S, Oka H, Iwasaki Y, Sumida H, Tanaka T, Tayama S, Jinnouchi H, Ogawa H.

J Cardiol. 2014 Aug;64(2):91-7. doi: 10.1016/j.jjcc.2013.11.018. Epub 2014 Jan 20.

2.

Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease.

Toyama K, Sugiyama S, Oka H, Iwasaki Y, Sumida H, Tanaka T, Tayama S, Jinnouchi H, Matsui K, Ogawa H.

Atherosclerosis. 2011 Jul;217(1):158-64. doi: 10.1016/j.atherosclerosis.2011.02.050. Epub 2011 Mar 10.

PMID:
21458815
3.

Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease.

Toyama K, Sugiyama S, Oka H, Iwasaki Y, Sumida H, Tanaka T, Tayama S, Jinnouchi H, Ogawa H.

PLoS One. 2012;7(7):e41369. doi: 10.1371/journal.pone.0041369. Epub 2012 Jul 19. Erratum in: PLoS One. 2013;8(1). doi:10.1371/annotation/83ad6bd2-c729-47b3-87f9-6994b428eada.

4.
5.

Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe.

Yamazaki D, Ishida M, Watanabe H, Nobori K, Oguma Y, Terata Y, Koyama T, Iino K, Kosaka T, Ito H.

Lipids Health Dis. 2013 Feb 4;12:9. doi: 10.1186/1476-511X-12-9.

6.
7.

Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.

Shioji K, Izuhara M, Mitsuoka H, Uegaito T, Matsuda M; Kishiwada Atherosclerosis Prevention Study (KAPS) Group.

Cardiovasc Ther. 2014 Jun;32(3):97-104. doi: 10.1111/1755-5922.12066.

PMID:
24456217
8.

Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.

Qu HY, Xiao YW, Jiang GH, Wang ZY, Zhang Y, Zhang M.

Pharm Res. 2009 Apr;26(4):958-64. doi: 10.1007/s11095-008-9798-6. Epub 2008 Dec 10.

PMID:
19082693
9.
10.
11.
12.

Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial).

Deedwania PC, Gupta M, Stein M, Ycas J, Gold A; IRIS Study Group.

Am J Cardiol. 2007 Jun 1;99(11):1538-43. Epub 2007 Apr 16.

PMID:
17531577
13.

Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia.

Stein EA, Strutt K, Southworth H, Diggle PJ, Miller E; HeFH Study Group.

Am J Cardiol. 2003 Dec 1;92(11):1287-93.

PMID:
14636905
15.

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care.

Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP.

Expert Opin Pharmacother. 2008 Apr;9(5):669-76. doi: 10.1517/14656566.9.5.669.

PMID:
18345946
16.

NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.

Satoh M, Tabuchi T, Itoh T, Nakamura M.

Clin Sci (Lond). 2014 Feb;126(3):233-41. doi: 10.1042/CS20130043.

PMID:
23944632
17.

Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.

Anagnostis P, Selalmatzidou D, Polyzos SA, Panagiotou A, Slavakis A, Panagiotidou A, Athyros VG, Karagiannis A, Mikhailidis DP, Kita M.

Int J Clin Pract. 2011 Jun;65(6):679-83. doi: 10.1111/j.1742-1241.2011.02655.x.

PMID:
21564441
18.

Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials.

Wlodarczyk J, Sullivan D, Smith M.

Am J Cardiol. 2008 Dec 15;102(12):1654-62. doi: 10.1016/j.amjcard.2008.08.014. Epub 2008 Sep 20.

PMID:
19064019
19.

Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.

Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M.

Am Heart J. 2004 Jul;148(1):e4.

PMID:
15215813
20.

Effects of atorvastatin and rosuvastatin on renal function: a meta-analysis.

Savarese G, Musella F, Volpe M, Paneni F, Perrone-Filardi P.

Int J Cardiol. 2013 Sep 10;167(6):2482-9. doi: 10.1016/j.ijcard.2012.05.010. Epub 2012 May 26.

PMID:
22633671

Supplemental Content

Support Center